Vector for expression of SpCas9-Zif268 in yeast after assembly with PID fragments: TEF1p-SpCas9::KanR-1xNLS-3xHA-1xNLS-Zif268-1xNLS-CYC1t (KanR cassette in place of the PID)

E. coli plasmid that contains the expression optimized genes for BB0405, BB0406, P66, BBA57, HtrA, RevA and BB0238

Mammalian expression of CoVMab7 heavy chain

Mammalian expression of CoVMab4 heavy chain

Mammalian expression of CoVMab7 light chain

Mammalian expression of CoVMab4 light chain

C. elegans let-858 3' UTR (Gateway Entry Clone)

Encodes Thr251Gly-EcPheRS Under Arabinose-Inducible (PBAD) Control

Mammalian expression of F1 nanobody upstream of human IgG1; F1 nanobody targets the receptor binding domain (RBD) of SARS-CoV-2 spike

Mammalian expression of E2 nanobody upstream of human IgG1; E2 nanobody targets the receptor binding domain (RBD) of SARS-CoV-2 spike

Mammalian expression of G6 nanobody upstream of human IgG1; G6 nanobody targets the receptor binding domain (RBD) of SARS-CoV-2 spike

Mammalian expression of C7 nanobody upstream of human IgG1; C7 nanobody targets the receptor binding domain (RBD) of SARS-CoV-2 spike

SQ171 fast growing strain supported by pCSacB plasmid

SQ171 strain supported by pRibo-T plasmid

Encodes Thr412Gly-CePheRS Alpha Subunit (Gateway Entry Clone)

Ready-to-use AAV Retrograde particles produced from AAV-CAG-hChR2-H134R-tdTomato (#28017). In addition to the viral particles, you will also receive purified AAV-CAG-hChR2-H134R-tdTomato plasmid DNA. Humanized channelrhodopsin H134R mutant fused to tdTomato, under the control of the CAG promoter. These AAV were produced with a retrograde serotype, which permits retrograde access to projection neurons. These AAV preparations are suitable purity for injection into animals.

Ptrc99A-PAmCherry for bacterial expression

Ribo-T with orthogonal anti-Shine-Dalgarno sequence, and pL G to T mutation

pTrc99A-mNeonGreen-mcdB for bacterial expression

SQ171 fast growing strain supported by pRibo-T plasmid